Investigating whether bacteria or other organisms are present in the bloodstream at the time of transcatheter aortic valve implantation (TAVI)
Not Applicable
Active, not recruiting
- Conditions
- Aortic stenosisBacteraemiaInfective endocarditisInfection - Other infectious diseasesCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12624000709549
- Lead Sponsor
- Dr Christopher Robson
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
undergoing a clinically indicated TAVI procedure via a transfemoral approach OR undergoing coronary angiography via a transfemoral approach (comparator group)
able to provide informed consent
Exclusion Criteria
known bacteraemia within 30 days prior to TAVI procedure
receipt of systemic antibiotic therapy within 5 days prior to TAVI procedure (other than procedural prophylaxis)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of periprocedural bacteraemia during TAVI procedures, assessed using culture of blood samples[ 6 days post TAVI procedure];Microbiology of periprocedural bacteraemia during TAVI procedures, assessed using culture of blood samples[ 6 days post TAVI procedure]
- Secondary Outcome Measures
Name Time Method